Northern Trust Corp Protalix Bio Therapeutics, Inc. Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 684,758 shares of PLX stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
684,758
Previous 731,742
6.42%
Holding current value
$1.05 Million
Previous $1.4 Million
24.79%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PLX
# of Institutions
70Shares Held
8.27MCall Options Held
227KPut Options Held
54.5K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.19MShares$1.82 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny963KShares$1.47 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA859KShares$1.31 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0615KShares$941,0800.0% of portfolio
-
Connor, Clark & Lunn Investment Management Ltd.483KShares$738,7980.01% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $76.1M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...